Cite

    Chronister, K. et al. (2019). Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low‐threshold primary health‐care opioid agonist treatment program. Drug and alcohol review. pp. 185-189. [Online].